methazolamide has been researched along with Diseases, Metabolic in 1 studies
Methazolamide: A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Z | 1 |
| Peng, M | 1 |
| Chen, P | 1 |
| Liu, C | 1 |
| Hu, A | 1 |
| Zhang, Y | 2 |
| Peng, J | 1 |
| Liu, J | 1 |
| Li, Y | 1 |
| Li, W | 1 |
| Zhu, W | 1 |
| Guan, D | 1 |
| Chen, H | 1 |
| Li, J | 1 |
| Fan, D | 1 |
| Huang, K | 1 |
| Lin, F | 1 |
| Zhang, Z | 1 |
| Guo, Z | 1 |
| Luo, H | 1 |
| He, X | 1 |
| Zhu, Y | 1 |
| Li, L | 1 |
| Huang, B | 1 |
| Cai, W | 1 |
| Gu, L | 1 |
| Lu, Y | 1 |
| Deng, K | 1 |
| Yan, L | 1 |
| Chen, S | 1 |
1 other study available for methazolamide and Diseases, Metabolic
| Article | Year |
|---|---|
Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry.
Topics: Angiotensin-Converting Enzyme 2; Animals; Cells, Cultured; Chlorocebus aethiops; COVID-19; COVID-19 | 2022 |